Disseminated Kaposi sarcoma following COVID-19 in a 61-year-old Albanian immunocompetent man: a case report and review of the literature

Background COVID-19 and its related anti-inflammatory treatment (steroids, immunomodulators) may induce the reactivation of latent bacterial, parasitic, and viral infections. According to our knowledge, no case of disseminated HHV-8-related Kaposi sarcoma (KS) after COVID-19 and its treatment has be...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of medical research Vol. 26; no. 1; pp. 152 - 6
Main Authors:	Gardini, Giulia, Odolini, Silvia, Moioli, Giovanni, Papalia, Dorothea Angela, Ferrari, Vittorio, Matteelli, Alberto, Caligaris, Silvio
Format:	Journal Article
Language:	English
Published:	London BioMed Central 20.12.2021 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Abdomen Acquired immune deficiency syndrome AIDS Anemia Antibiotics Antigens Biomedicine Biopsy Case Report Coronaviruses COVID-19 COVID-19 - diagnosis COVID-19 - drug therapy COVID-19 - genetics Databases, Chemical Diabetes Digital libraries Disease transmission Drug dosages Gallbladder diseases Health aspects HHV-8 HIV Human immunodeficiency virus Humans Hypertension Infection Infections Infectious Diseases Interleukin-6 - metabolism Interleukins Internal Medicine Kaposi sarcoma Kaposi's sarcoma Kaposis sarcoma Laboratories Language Latent infection Lymphatic system Male Medical tests Medicine Medicine & Public Health Middle Aged Oncology Pathogenesis Reactivation Rehabilitation Sarcoma, Kaposi - complications Sarcoma, Kaposi - drug therapy Sarcoma, Kaposi - genetics SARS-CoV-2 - drug effects SARS-CoV-2 - genetics SARS-CoV-2 - pathogenicity Severe acute respiratory syndrome coronavirus 2 Skin Steroids Surgery University and college libraries Viral infections Virus diseases Albania COVID-19 Latent infection Kaposi sarcoma HHV-8 Reactivation
ISSN:	2047-783X, 0949-2321, 2047-783X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!